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Summary A cytofluorometric assay allowing the measurement of thymidine phosphorylation in single cells
had been established (Hengstschlager & Wawra, 1993). This assay enables us to correlate intracellular
thymidine kinase (TK) activity with the DNA content of single cells.
Enzyme activity levels from neuroblastoma cells and normal fibroblasts derived from the same patient were
determined. Using this cytofluorometric assay in a mixture of both cell types the neoplastic cells could be
distinguished from the normal fibroblasts because of their higher TK level. A human lymphoblastoid cell line
was compared with the cell line KG-1, derived from an acute myelogenous leukaemia, in the same way. The
increased enzyme activity enabled us to detect KG-1 cells in a mixture with an 10,000-fold excess of Epstein
Barr virus transformed lymphocytes.
Thymidine kinase, ATP:thymidine 5'phosphotransferase (EC
2.7.1.21), converts thymidine (Thd) to thymidine monophos-
phate (TMP). This enzyme of the pyrimidine nucleotide sal-
vage pathway occurs mainly in two forms in human tissue,
TK1 and TK2 (Shows et al., 1979). The cytosolic enzyme
TK1, dominates in replicating cells, but is absent in resting
cells (Bello, 1974). Therefore high levels of TK1 activity are
found in foetal and neoplastic cells, but its activity is low in
non-growing adult tissue (Gordon et al., 1968; Herzfeld &
Greengard, 1980; Bardot et al., 1991). The second type of the
enzyme, TK2, is ofmitochondrial origin and causes the lower
and constant level of TK activity in resting cells (Adler &
McAuslin, 1974).
A relationship was observed between elevated serum TK
levels and cancer stage and prognosis in patients with non-
Hodgkin's and Hodgkin's lymphoma (Gronowitz et al.,
1983), in patients with acute myelogenous leukaemia
(Hagberg et al., 1984), chronic lymphocytic leukaemia
(Kallander et al., 1984) and multiple myeloma (Simonsson et
al., 1985). The increase of serum total TK activity appears to
originate from the tumour cells and seems to reflect intracel-
lular TK1 activity (O'Neill et al., 1987; Kallander et al.,
1987). All these observations suggest that quantitative
analyses of TK would distinguish malignant from normal
cells.
In order to study the regulation of TK in connection with
cellular proliferation, we have established a cytofluorometric
assay that allows the measurement of thymidine phosphory-
lation in single cells and its correlation with the cellular DNA
content (Hengstschldger & Wawra, 1993). We synthesised a
fluorescent thymidine analogue that is phosphorylated by TK
in cell free extracts. This was taken up and phosphorylated
by cells in culture. Therefore the cytofluorometric signal of
the accumulated fluorochrome reflects the TK activity of the
cell (Wawra, 1988). Simultaneous measurement of the cel-
lular DNA content allows the correlation of TK activity with
the phase of growth in mixed cell populations and enables
the detection of subpopulations with elevated TK activity in
an excess of normal cells.
Using the traditional radioactive TK assay we determined
the total intracellular TK activity of four cell types: (1)
normal human fibroblasts derived from a neuroblastoma
patient, (2) neuroblastoma cells from the same patient, (3) a
human lymphoblastoid cell line and (4) the human cell line
KG-1, derived from an acute myelogenous leukaemia. In
mixtures of either neuroblastoma cells and normal fibroblasts
or cells of the lymphoblastoid cell line and KG-I we distin-
guished neoplastic from normal cells by their intracellular
TK activity using this cytofluorometric assay. The fraction of
tumour cells in the mixtures was determined.
Material and methods
Chemicals
5-amino-2-deoxyuridine (AUdR) and 5-dimethylamino-1-
naphthalene-sulfonyl-chloride (DANS) were obtained from
Sigma, Deisenhofen, West Germany. Ethidium Bromide
(EtBr) was purchased from SERVA, Heidelberg, West Ger-
many. Synthesis and purification of the fluorescent thymidine
analogue AUdR/DANS are described previously (Heng-
stschlager & Wawra, 1993).
Cells
Human neuroblastoma cells, derived from a female patient
with an aggressive tumour, were cultivated after tumour
resection. During cultivation the amount of normal fibro-
blasts in this heterogeneous population of normal and neo-
plastic cells increased. The mixture was analysed by the
cytofluorometric TK assay after growing in vitro for 6
months. We were also able to cultivate neuroblastoma cells
and normal fibroblasts of the same patient separately. This
allowed the characterisation and analysis of these two cell
types.
A normal human lymphocyte cell line was established by
transforming phytohemaglutinin stimulated peripheral blood
cells with Epstein Barr virus (EBV). The cell line KG-1
(CCL246) was obtained from the American Type Culture
Collection, Rockville, Maryland. Tissue cultures were main-
tained at 37'C, 5%CO2 in 75cm2 flasks containing RPMI
medium supplemented with 10% foetal calf serum. Cells were
passaged after reaching a density of about 2-4 x 106 cell per
ml. The cell lines were routinely screened for the absence of
mycoplasma.
Thymidine kinase assay in cellfree extracts
Cells were lysed in 10 mM Tris-HCl (pH 7.5), 160 mM KCl,
250 mM sucrose, 1.5 mM Mg C12, 50 mM e-aminocapronic
acid and 3 mM P-mercaptoethanol containing 0.5% Nonidet-
P40 by keeping 10 min at 0'C. Conventional thymidine
kinase assays using radioactive thymidine were performed as
described previously (Wawra et al., 1981). Protein concentra-
tions in the extracts were determined according to the
method of Bradford (1976).
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Simultaneous measurement ofintracellular TK activity and
DNA content
Detailed information about the cytofluorometric TK assay is
described by Hengstschlager and Wawra (1993). Cells were
exposed to 1.5 gmol l' AUdR/DANS for 1 h in serum free
RPMI medium. Thereafter, the cells were trypsinised, cent-
rifuged and the pellet was resuspended in PBS.25 ytmol 1'
EtBr was added to stain DNA. Fluorescence intensity
reflecting thymidine kinase activity and DNA content were
simultaneously measured in a Partec PAS-II flow
cytometer.
Results
Total intracellular TK activity measured in extracts of four
cell types are presented in Table I. Whereas no great
difference between the enzyme levels of normal fibroblasts
and Epstein Barr virus transformed lyrnphocytes could be
detected, these results indicate that TK activity in the
analysed neoplastic cells is higher than in the corresponding
normal cells. The ratio of enzyme activities in the matched
pair of normal fibroblasts and neuroblastoma cells, derived
from the same patient, can be compared with the ratio in the
pair of the lymphoblastoid cell line and KG-i.
DNA content and TK activity of normal human fibro-
blasts were measured simultaneously in the Flow Activated
Cell Analyser (Figure 1). Starting from a low level in GI, TK
activity increases during S-phase and declines in G2 (Figure
lb). Determination of DNA cortent (Figure la) leads to a
typical distribution of diploid logarithmically growing cells.
Staining with EtBr in vivo caused a more diffuse pattern than
e.g. DAPI (4,6-diamino-2-phenylindol-dihydrochloride) stain-
ing in fixed cells. For this analysis it is not possible to use
DAPI to stain DNA, because the emission of DAPI can not
be separated from the emission of the fluorescent thymidine
analogue. Fixation of the cells before the flow cytometric
measurement must also be avoided. After fixation the
thymidine analogue would permeate out of the cell and the
intracellular fluorescence intensity would not reflect the TK
activity anymore (Hengstschliiger & Wawra, 1993).
Cytofluorometric analysis of neuroblastoma cells, derived
from the same patient, is shown in Figure 2. The tetraploidy
of these cells could be confirmed by cytogenetic analysis
(data not shown). Although intracellular TK activity varied
more than in the compared fibroblasts, the enzyme level in
GI, S and G2-phase was consistantly higher in these neuro-
blastoma cells. The ratio of TK activities in neoplastic to
normal cells (T/N = 5.66), determined by conventional
radioactive assay, could be verified.
Figure 3 presents the analysis of a mixture of normal
fibroblasts and neuroblastoma cells after growing in vitro for
6 months. The relation between normal and neoplastic cells is
about 1:10. Looking at the DNA distribution (Figure 3a) it
is hard to distinguish between these two cell types. The first
large DNA peak represents diploid fibroblasts in GI phase,
Table I Comparison of TK activity from (a) matched normal
human fibroblasts and neuroblastoma cells and (b) EBV transformed
human lymphocytes and a cell line obtained from an acute
myelogenous leukaemia
Cell type TK activita T/Nb
(a)
Normal fibroblasts 191 5.7
Neuroblastoma 1081
(b)
EBV transformed lymphocytes 184 4.9
KG-1 896
aSpecific TK activity is given in pmol TMP formed per mg protein
per h. bRatio of TK activities in a 'matched' pair of neoplastic (T)
and normal (N) cells.
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Figure 1 Simultaneous flow cytometric measurement of DNA
content and TK activity in normal human fibroblasts. a, Distri-
bution of DNA (abscissa) versus cell number (ordinate). b, Con-
tent of DNA (abscissa) versus intracellular accumulation of the
fluorescent thymidine analogue (= TK activity)(ordinate).
whereas the second peak originates from GI of the tetraploid
tumour cells. The analysis of TK enzyme levels lead to a
clear cut between normal and neuroblastoma cells (Figure
3b).
To demonstrate that it is possible to discriminate cells,
which have identical DNA content, by their different TK
activities, we mixed Epstein Barr virus transformed lym-
phocytes with cells of the acute myelogeneous leukaemia line
KG-1. Different mixtures of these two cell types were
analysed. In Figure 4 the ratio of KG-1 cells to lymphocytes
is 1:1000. It is not possible to distinguish these two cell lines
by their DNA content (Figure 4a). A good separation of
normal and leukaemic cells can be achieved by the flow
cytometric measurement of TK enzyme levels (Figure 4b).
This assay makes possible the detection of 1 KG-1 cell in
10,000 Epstein Barr virus transformed lymphocytes (Figure
5). The limitating step of these analyses is not the relation
between the two cell types but the total amount of cells that
can be analysed. About 30 to 50 tumour cells can be detected
as a subpopulation with elevated TK activity in an excess of
normal cells.
Discussion
The correlation of increased TK level with cancer stage and
prognosis is well documented (Gronowitz et al., 1983;
Hagberg et al., 1984; Kal!ander et al., 1984; Simonsson et al.,
1985). The value of studying total intracellular TK activity
originates in the hypothesis that elevated serum TK level
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Figure 2 Simultaneous flow cytometric measurement of DNA Figure 4 Flow cytometric analysis of DNA content and TK
content and TK activity in tetraploid neuroblastoma cells. (See activity in a mixture of Epstein Barr virus transformed lympho-
Figure 1 for details). cytes and the acute myelogenous leukaemia line KG-1. Lympho-
blastoid cells and leukaemic cells were mixed 1000 to 1, the
measured ratio by flow cytometry was 915:1. (see Figure I for
details).
a
reflects the increased cellular enzyme status (O'Neill et al.,
1987; Kallander et al., 1987). The high intracellular TK
activity in neoplastic cells may be caused by (1) a longer
S-phase in relation to GI and G2 phase in their cell cycle, (2)
a higher increase of TK in S, starting from a low level in GI
or (3) a consistently higher TK in GI, S and G2-phase. Our
co simultaneous analysis of DNA content and TK activity of
X* _ _neuroblastoma cells compared to matched normal fibroblasts
o z supports the idea of elevated TK levels in G1, S and G2-
phase in cancer cells. Moreover the well known increase of E0_TK activity at the G1/S boundary could be detected in E
neuroblastoma cells. Gordon et al. (1968) published (e.g.) a Z ratio T/N = 2.53 of enzyme activities in the case of Ewing's
sarcoma compared to normal bone tissue. Our results
b DNAcontent observe that neuroblastoma cells, a comparable solid tumour,
a display 5.7-fold higher TK level than normal fibroblasts,
L -...... derived from the same patient. This larger increase can be
4; _ .-s;o.*%%
`
caused by the tetraploidy of the tumour cells in comparison
CU.... > .. to the matched diploid fibroblasts. A correlation between the
co relative numbers of chromosomes and the activities of
enzymes encoded by their genes was shown for thymidylate
C | . ;5. . . | synthetase, thymidine kinase and galactokinase (Bardot et al.,
Figure 3 Flow cytometric analysis of DNA contents and TK
activity in a mixture of normal, diploid fibroblasts and tetraploid
neuroblastoma cells, derived from the same patient. Normal and
tumour cells were mixed 1:10, the measured ratio by flow
l -r- 1- 1 ------1- cytometry was 1:10.4 (see Figure 1 for details).MEASUREMENT OF INTRACELLULAR TK ACTIVITY 1025
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Figure 5 Visualisation of a low fraction of neoplastic cells. On
the left side the flow cytometric analysis of a large amount of
EBV transformed lymphocytes is shown. The same cells were
mixed with KG-1 cells in the ratio of 10,000 to 1 (measured ratio
by flow cytometry 9368:1). The simultaneous cytometric measure-
ment of DNA content and TK activity of this mixture is shown
on the right side. (see Figure 1 for details).
1991). Beside other biological parameters including MYCN
(formerly N-myc) amplification, chromosome 1 aberrations
and ploidy level (Brodeur, 1990), TK activity change could
be a useful clinical tool in neuroblastoma. In connection with
these tumour markers intracellular TK activity could provide
additional information about the proliferation rate ofcells. It
would be of great interest if there exists a correlation between
the prognosis and the level of TK activity in neuroblastoma.
In mixtures of a lymphoblastoid cell line and the acute
myelogenous leukaemia line KG-1, we were able to detect 1
cell with elevated TK activity in 10,000 normal cells. We
chose this artificial mixture to demonstrate that these two
lines, which are absolutely identical in the DNA pattern, can
be discriminated by their TK activities. Unstimulated human
lymphocytes isolated from a healthy donor display an almost
undetectable intracellular TK activity level (data not shown).
Therefore the TK change between normal nondividing lym-
phocytes and leukaemic cells is very high. The amount of
neoplastic cells should be easier to determine in peripheral
blood, isolated from leukaemia patients, than in the used
mixture of proliferating lymphocytes and KG-1.
In comparison to the traditional radioactive approach the
advantages of the described new cytofluorometric TK assay
are obvious. This assay is non radioactive, not time consum-
ing and very sensitive. The simultaneous measurement of the
cellular DNA content enables the correlation of TK activity
with the phase of growth in any mixed cell population. There
is reason to believe, that this method is useful for other
applications besides cell cultures, e.g. primary cells, isolates
of solid tumours etc. After incubation with the fluorescent
thymidine analogue, without DNA staining, the cells are still
alive.
In future we plan to use a fluorescent activated sorting
system in order to find out if it is possible to separate
neoplastic cells from normal cells by their TK activity.
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